Matches in SemOpenAlex for { <https://semopenalex.org/work/W3167293810> ?p ?o ?g. }
- W3167293810 endingPage "e2021010" @default.
- W3167293810 startingPage "e2021010" @default.
- W3167293810 abstract "The coronavirus disease of 2019 (COVID-19) has become a global pandemic with rapid rate of transmission and fatalities worldwide. Scientists have been investigating a host of drugs that may be rechanneled to fight this malaise. Thus, in this current computational study we carried out molecular docking experiments to assess the bridging potentials of some commercial drugs such as chloroquine, hydroxychloroquine, lopinavir, ritonavir, nafamostat, camostat, famotidine, umifenovir, nitazoxanide, ivermectin, and fluvoxamine at the interface between human ACE2 and the coronavirus spike glycoprotein complex. This is aimed at ascertaining the ability of these drugs to bridge and prevent the complexing of these two proteins. The crystal structure of human ACE2 and the coronavirus spike glycoprotein complex was retrieved from protein database, while the selected drugs were retrieved from PubChem data base. The proteins and drugs were prepared for docking using Cresset Flare software. The docking was completed via AutoDock Vina module in Python Prescription software. The best hit drugs with each receptor were selected and their molecular interactions were analyzed using BIOVIA’s Discovery Studio 2020. The best hit compounds on the human ACE2 were the lopinavir (-10.1 kcal/mol), ritonavir (-8.9 kcal/mol), and nafamostat (-8.7 kcal/mol). Ivermectin, nafamostat, and camostat with binding energy values -9.0 kcal/mol, -7.8 kcal/mol, and -7.4 kcal/mol respectively were the hit drugs on the coronavirus spike glycoprotein. Nafamostat showed a dual bridging potential against ACE2 and spike glycoprotein, and could therefore be a promising lead compound in the prevention and control of this disease." @default.
- W3167293810 created "2021-06-22" @default.
- W3167293810 creator A5033471234 @default.
- W3167293810 creator A5043614251 @default.
- W3167293810 creator A5046971033 @default.
- W3167293810 creator A5072029827 @default.
- W3167293810 creator A5078317802 @default.
- W3167293810 creator A5088530823 @default.
- W3167293810 date "2021-06-14" @default.
- W3167293810 modified "2023-10-16" @default.
- W3167293810 title "Blocking the interactions between human ACE2 and coronavirus spike glycoprotein by selected drugs: a computational perspective" @default.
- W3167293810 cites W1987665528 @default.
- W3167293810 cites W2014359324 @default.
- W3167293810 cites W2064392331 @default.
- W3167293810 cites W2075689919 @default.
- W3167293810 cites W2103072895 @default.
- W3167293810 cites W2115840539 @default.
- W3167293810 cites W2126707939 @default.
- W3167293810 cites W2134967712 @default.
- W3167293810 cites W2169122205 @default.
- W3167293810 cites W2990279752 @default.
- W3167293810 cites W3002539152 @default.
- W3167293810 cites W3008362582 @default.
- W3167293810 cites W3013694216 @default.
- W3167293810 cites W3014248459 @default.
- W3167293810 cites W3014850166 @default.
- W3167293810 cites W3015190630 @default.
- W3167293810 cites W3024176830 @default.
- W3167293810 cites W3030355749 @default.
- W3167293810 cites W3033543683 @default.
- W3167293810 cites W3099851774 @default.
- W3167293810 cites W3109173464 @default.
- W3167293810 cites W3113244803 @default.
- W3167293810 cites W3119543673 @default.
- W3167293810 cites W3210011760 @default.
- W3167293810 cites W4230362274 @default.
- W3167293810 doi "https://doi.org/10.5620/eaht.2021010" @default.
- W3167293810 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8421753" @default.
- W3167293810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34130375" @default.
- W3167293810 hasPublicationYear "2021" @default.
- W3167293810 type Work @default.
- W3167293810 sameAs 3167293810 @default.
- W3167293810 citedByCount "3" @default.
- W3167293810 countsByYear W31672938102021 @default.
- W3167293810 countsByYear W31672938102022 @default.
- W3167293810 crossrefType "journal-article" @default.
- W3167293810 hasAuthorship W3167293810A5033471234 @default.
- W3167293810 hasAuthorship W3167293810A5043614251 @default.
- W3167293810 hasAuthorship W3167293810A5046971033 @default.
- W3167293810 hasAuthorship W3167293810A5072029827 @default.
- W3167293810 hasAuthorship W3167293810A5078317802 @default.
- W3167293810 hasAuthorship W3167293810A5088530823 @default.
- W3167293810 hasBestOaLocation W31672938101 @default.
- W3167293810 hasConcept C104317684 @default.
- W3167293810 hasConcept C142724271 @default.
- W3167293810 hasConcept C159110408 @default.
- W3167293810 hasConcept C185592680 @default.
- W3167293810 hasConcept C2775905019 @default.
- W3167293810 hasConcept C2777648638 @default.
- W3167293810 hasConcept C2779134260 @default.
- W3167293810 hasConcept C2780152424 @default.
- W3167293810 hasConcept C3008058167 @default.
- W3167293810 hasConcept C41685203 @default.
- W3167293810 hasConcept C524204448 @default.
- W3167293810 hasConcept C55493867 @default.
- W3167293810 hasConcept C71924100 @default.
- W3167293810 hasConcept C86803240 @default.
- W3167293810 hasConcept C98274493 @default.
- W3167293810 hasConceptScore W3167293810C104317684 @default.
- W3167293810 hasConceptScore W3167293810C142724271 @default.
- W3167293810 hasConceptScore W3167293810C159110408 @default.
- W3167293810 hasConceptScore W3167293810C185592680 @default.
- W3167293810 hasConceptScore W3167293810C2775905019 @default.
- W3167293810 hasConceptScore W3167293810C2777648638 @default.
- W3167293810 hasConceptScore W3167293810C2779134260 @default.
- W3167293810 hasConceptScore W3167293810C2780152424 @default.
- W3167293810 hasConceptScore W3167293810C3008058167 @default.
- W3167293810 hasConceptScore W3167293810C41685203 @default.
- W3167293810 hasConceptScore W3167293810C524204448 @default.
- W3167293810 hasConceptScore W3167293810C55493867 @default.
- W3167293810 hasConceptScore W3167293810C71924100 @default.
- W3167293810 hasConceptScore W3167293810C86803240 @default.
- W3167293810 hasConceptScore W3167293810C98274493 @default.
- W3167293810 hasIssue "2" @default.
- W3167293810 hasLocation W31672938101 @default.
- W3167293810 hasLocation W31672938102 @default.
- W3167293810 hasOpenAccess W3167293810 @default.
- W3167293810 hasPrimaryLocation W31672938101 @default.
- W3167293810 hasRelatedWork W1594539819 @default.
- W3167293810 hasRelatedWork W1984029386 @default.
- W3167293810 hasRelatedWork W2007257620 @default.
- W3167293810 hasRelatedWork W2058674645 @default.
- W3167293810 hasRelatedWork W2130867670 @default.
- W3167293810 hasRelatedWork W2766845742 @default.
- W3167293810 hasRelatedWork W3090574558 @default.
- W3167293810 hasRelatedWork W3106579324 @default.
- W3167293810 hasRelatedWork W4213038553 @default.
- W3167293810 hasRelatedWork W4312202637 @default.